ARTICLE | Clinical News
Pixantrone regulatory update
February 15, 2010 8:00 AM UTC
FDA postponed an Oncologic Drugs Advisory Committee meeting that was planned for Feb. 10 due to weather conditions in Washington. The meeting was scheduled to discuss an NDA for Pixuvri pixantrone to...